AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

DUKEMOUNT CAPITAL PLC

Share Issue/Capital Change May 1, 2020

4974_rns_2020-05-01_f955a2a8-de61-484b-863b-00d3317499a7.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 6745L

Dukemount Capital PLC

01 May 2020

Dukemount Capital PLC

01 May 2020      

01 May 2020

Dukemount Capital Plc

("Dukemount" or "the Company")

Admission To Trading For Bonus Shares

It was previously announced on 31 January 2019 that following the successful completion of the first 2 transactions, the directors decided to award the Executive Chairman, Mr Geoffrey Dart, a bonus of £80,000. Mr Dart agreed to receive settlement of this bonus in the form of ordinary shares in the company which were issued in two equal tranches at a price of 0.30 pence per share. The first tranche of shares was issued immediately before the AGM and the second tranche immediately after the AGM held on 1 February 2019. The total number of shares issued was 26,666,666. The shares were not admitted for trading on the London Stock Exchange at the time of issue. Admission to trading for these 'Bonus' shares is now expected to be on 5 May 2020

For further information, please visit www.dukemountcapitalplc.com or contact:

Dukemount Capital Plc Via St Swithins PR
Geoffrey Dart
St Swithins PR (Media and Investor Enquiries) Tel: +44 (0) 1732 521132
Gary Middleton [email protected]
Peterhouse Capital  Limited Tel: +44 (0) 207 469 0930
Lucy Williams/Duncan Vasey

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

MSCFLFLIEAILIII

Talk to a Data Expert

Have a question? We'll get back to you promptly.